跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,912 条关于
“Beijing Huahai Keyuan”
全部
2,912
临床试验
2,001
药物
485
机构
143
资讯
283
去年
BON Secures $32 Million Deal for Novel Postbiotic Blood Sugar Management Solution
2个月前
China's Pharma Industry Charts Innovation-Driven Future at Landmark Beijing Conference
去年
AstraZeneca Invests $2.5 Billion in Beijing to Establish Sixth Global R&D Center
去年
BeOne Medicines Expands Beijing R&D Center to Accelerate Oncology Drug Development
10个月前
AstraZeneca Establishes Sixth Global R&D Center in Beijing to Accelerate AI-Driven Drug Discovery
去年
Hanmi's BH3120 Shows Promise in Phase 1 Trials for Advanced Solid Tumors
去年
Hanmi's BH3120 Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Hanmi Pharmaceutical Advances BH3120 Immunotherapy Trials Targeting Solid Tumors
去年
Livzon's Dual-Target IL-17A/F Antibody LZM012 Outperforms Secukinumab in Phase III Psoriasis Trial
去年
China Courts Signal Shift in Polymorph Patent Standards as Beijing IP Court Lowers Inventiveness Bar
第 1 页,共 29 页
上一页
下一页